Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
about
PET probe-guided surgery: applications and clinical protocolA Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft ModelSynthesis, isolation and purification of [(11)C]-cholineCholine PET for monitoring early tumor response to photodynamic therapyRadiosyntheses using fluorine-18: the art and science of late stage fluorinationKinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.Phosphorylation of the yeast choline kinase by protein kinase C. Identification of Ser25 and Ser30 as major sites of phosphorylation.Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancerAdvances in bladder cancer imaging.Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneHighlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).The next generation of positron emission tomography radiopharmaceuticals in oncology.Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate CancerUpdate of PET and PET/CT for hepatobiliary and pancreatic malignancies.PET/CT Imaging and Radioimmunotherapy of Prostate CancerDetection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging.Should positron emission tomography/computed tomography be the first rather than the last test performed in the assessment of cancer?Targeted molecular imaging in oncology: focus on radiation therapy.A choline derivate-modified nanoprobe for glioma diagnosis using MRI.Imaging in genitourinary cancer from the urologists' perspective.Choline autoradiography of human prostate cancer xenograft: effect of castrationNew horizons in prostate cancer imaging.Novel tracers and their development for the imaging of metastatic prostate cancer.Molecular and functional imaging for detection of lymph node metastases in prostate cancer.State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.Estimation of human absorbed dose for (166)Ho-PAM: comparison with (166)Ho-DOTMP and (166)Ho-TTHMP.Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.A fully-automated one-pot synthesis of [18F]fluoromethylcholine with reduced dimethylaminoethanol contamination via [18F]fluoromethyl tosylate.Beyond FDG: novel PET tracers for cancer imaging.Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT.Occult Prostate Cancer Detected with 18F-Fluorocholine Positron Emission Tomography/Computed Tomography.Molecular imaging and fusion targeted biopsy of the prostate.Optimization of temporal sampling for 18F-choline uptake quantification in prostate cancer assessment.Troubleshooting for F-18 Fluorocholine Synthesis: An Institutional Experience
P2860
Q21245588-F24424FB-1766-4DF6-88A7-B0DC8C6950C9Q27324332-405742FA-B55B-49B2-80B9-1EAF09C19328Q28831129-DD82A3B2-4DC8-4FE1-8B42-E114FD627A07Q33518345-C6EBD955-BCD7-4C4E-890F-B7D12CC534BAQ34074437-4EAE83BB-04FA-4BD3-93E2-A0DB9956E5AFQ34114265-6CD57BC7-5B68-4161-8398-7B970104397BQ34411119-071988EE-B729-4798-9DB7-5B838A88F22DQ34465066-6D8B8BE9-929A-4986-8EDA-A74104BD3269Q34662750-701CE12C-6F35-4C3F-9763-B1466C90B562Q35068005-0807B347-CF23-4DCB-A488-79F129677764Q35108246-399C6431-958A-46C5-98FC-36DC0B948785Q35525690-22C680F2-2239-49E0-ACC9-E98A3A062A14Q35987985-81DD102E-A4E5-4EA6-93CD-6227496DB534Q36039090-B2C9D27D-0E60-43D7-B3B0-382E2447FBA5Q36066047-9AAA5133-76A7-4D36-BD2F-71FBEE92F7C4Q36085426-BA321BD9-A255-437A-99E6-99EE17AB46C5Q36103698-E9863E60-6607-4CAD-8337-A159D6B2E240Q36286485-E9D48E22-7631-4F1C-8CDD-E9B8F5DB735BQ36528175-860D5FAC-006A-4BCF-8B24-8C7CFEEF5F74Q36747329-18D85D78-FFC9-4F4B-850E-D62877704D47Q36834536-A1EDCC2F-F23B-4CBA-B301-44C699BA1538Q37052606-066F51EF-0E9B-40B4-A308-8DF4FC978550Q37242030-1619C7E6-D74D-4FFE-ADC9-10298AE8235EQ37321810-DF6734D6-BF0A-4729-9C8E-C86A78CF0830Q38119113-4FCD240B-4FD1-4B05-9F79-942DFE67B8C3Q38340518-A1345ECD-5AF3-4983-B3D3-72D3A56BA1D7Q38479113-7385DF6D-60C5-469F-A23C-5B48E944E453Q38532173-6A6EEAEE-B021-4033-929F-3BD2E8E9AEB5Q38924757-B9C2B354-780A-4507-AE6C-A9A954883981Q39449818-EC81E9DD-0B6F-499A-9939-B77A649EB05EQ39490864-27C0D30B-2786-4835-952C-8594B9547B9EQ39571686-7F1B577B-9CBF-44AD-9378-35364A5B8B53Q41660750-25CDF13C-87BA-4EC8-82B8-59FB515DAF81Q41840589-5DE22F11-6519-445A-B20A-F51A8815EF35Q41840675-8183079A-621A-4117-B665-D8A79E6D40ABQ41862863-622694C3-6FE3-4D75-B60C-D50BED2A9E0FQ42286329-9C1F8CD2-46B9-4B2F-9285-C834E1DBA6F3Q47608215-CA4DAE49-76D4-4D05-A026-D8B1C9C07838Q55395878-AB1751B9-AA7F-4B21-9484-8567F7E17221Q58593205-BFE9993F-0173-461C-B31C-408AE356E20D
P2860
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
@en
type
label
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
@en
prefLabel
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
@en
P2093
P1476
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
@en
P2093
Baldwin SW
Coleman RE
DeGrado TR
P304
P407
P577
2001-12-01T00:00:00Z